MENU
+Compare
OVID
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$0.34
Change
+$0.02 (+6.25%)
Capitalization
23.94M

OVID Ovid Therapeutics Forecast, Technical & Fundamental Analysis

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders... Show more

OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for OVID with price predictions
Apr 23, 2025

OVID's RSI Oscillator climbs out of oversold territory

The RSI Indicator for OVID moved out of oversold territory on April 11, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In of the 27 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on OVID as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OVID just turned positive on April 14, 2025. Looking at past instances where OVID's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where OVID advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OVID declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OVID broke above its upper Bollinger Band on April 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for OVID entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.351) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (42.194) is also within normal values, averaging (252.992).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OVID’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OVID’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

OVID is expected to report earnings to rise 10.23% to -14 cents per share on May 08

Ovid Therapeutics OVID Stock Earnings Reports
Q1'25
Est.
$-0.14
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.34
Q1'24
Beat
by $0.05
The last earnings report on March 11 showed earnings per share of -12 cents, beating the estimate of -17 cents. With 759.81K shares outstanding, the current market capitalization sits at 23.94M.
A.I. Advisor
published General Information

General Information

Provides medicines to children and adults with neurological disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
441 Ninth Avenue
Phone
+1 646 661-7661
Employees
40
Web
https://www.ovidrx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVRE2.150.11
+5.39%
SaverOne 2014 Ltd.
TRIP12.330.44
+3.70%
TripAdvisor
ARES145.954.23
+2.98%
Ares Management Corp
TILE18.270.10
+0.55%
Interface
OPAD1.29-0.11
-7.86%
Offerpad Solutions

OVID and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OVID has been closely correlated with AVTE. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if OVID jumps, then AVTE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVID
1D Price
Change %
OVID100%
+12.07%
AVTE - OVID
88%
Closely correlated
-0.72%
SYRE - OVID
46%
Loosely correlated
+1.86%
NAUT - OVID
36%
Loosely correlated
-5.10%
TVTX - OVID
36%
Loosely correlated
+5.16%
KPRX - OVID
36%
Loosely correlated
+3.31%
More

Groups containing OVID

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVID
1D Price
Change %
OVID100%
+12.07%
OVID
(2 stocks)
92%
Closely correlated
+2.36%